Skip to main content
NewslettersWatchlist

Cansortiuminc(TIUM-U-CN)
CSE

Today's Change
Delayed Last Update
Day Low0.0750
Day High0.0850
Open:0.0750
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Introducing Hyer Kind: FLUENT’s New Cannabis Concentrates Line, Exclusively Available in Florida
Newswire.ca
RIV Capital and Cansortium Receive New York State Cannabis Control Board Approval for Change of Control
Newswire.ca
RIV Capital and Cansortium Celebrate the Successful Launch of MOODS in New York
Newswire.ca
Cansortium Announces Shares for Debt Settlement
Newswire.ca
RIV Capital Announces Shareholder Approval of Business Combination with Cansortium and Cansortium Announces Shareholder Approval of the Amendment Proposal
Newswire.ca
Cansortium Reports Second Quarter 2024 Results
Newswire.ca
RIV Capital and Cansortium Inc. Provide Integration Update Ahead of Completing Merger
Newswire.ca
Cansortium Schedules Second Quarter 2024 Conference Call for Thursday, August 22 at 4:30 P.M. ET
Newswire.ca
RIV Capital Strengthens Senior Leadership Team Ahead of Anticipated Transformational Merger with Cansortium Inc.
PR Newswire
Cansortium Announces Shares for Debt Settlement
PR Newswire
Cansortium Reports First Quarter 2023 Results
Newswire.ca
FLUENT Issues Statement on Failed Cannabis Bills in Texas
Newswire.ca
Cansortium Schedules First Quarter 2023 Conference Call for Wednesday, May 31 at 4:30 P.M. ET
Newswire.ca
FLUENT Moves U.S. Headquarters to Tampa, Florida
Newswire.ca
Cansortium Schedules Fourth Quarter and Full Year 2022 Conference Call for Monday, May 1 at 4:30 P.M. ET
PR Newswire
Cansortium Appoints Jeffrey Batliner as Chief Financial Officer
Newswire.ca
Cansortium Announces Closing of US$3 Million Private Placement
Newswire.ca
Legendary Breeder Origins TK Selects and Fluent Form Licensing Agreement, Bringing Premium Genetics to the Florida Medical Cannabis Market
Newswire.ca
Cansortium Announces Shares for Debt Settlement
Newswire.ca
Cansortium Restructures Short-Term Contingent Liability
PR Newswire
Cansortium Schedules Third Quarter 2022 Conference Call for Tuesday, November 29 at 4:30 P.M. ET
PR Newswire
Cansortium Announces Change in Chief Financial Officer

Profile

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.